Literature DB >> 9724057

Functional GIP receptors are present on adipocytes.

R G Yip1, M O Boylan, T J Kieffer, M M Wolfe.   

Abstract

In addition to its important role in maintaining glucose homeostasis, it has recently become apparent that glucose-dependent insulinotropic polypeptide (GIP) is also involved in different steps of lipid metabolism. GIP has been shown to stimulate the release of lipoprotein lipase from fat, as well as increase the rate of fat incorporation into adipose tissue. Moreover, GIP has been shown to increase the clearance rate of chylomicrons in the circulation and to inhibit the action of glucagon. Despite evidence for GIP effects on fat tissue, GIP receptors have not been identified in fat cells or tissues. The present study was undertaken to identify GIP receptors in isolated adipocytes, as well as to identify GIP receptors in the established fat cell line, differentiated 3T3-L1. RNAse protection analysis demonstrated the presence of GIP receptor transcripts in rat adipocytes. A polyclonal GIP receptor antiserum directed at the N-terminus of the receptor detected the presence of GIP receptors in both rat fat and differentiated 3T3-L1 cells by Western blot analysis. Moreover, [125I] GIP binding assays revealed both specific and displaceable GIP binding sites in differentiated 3T3-L1 cells (IC50 = 10(-9) M). When undifferentiated 3T3-L1 cells, which appear to express relatively few GIP receptors, were incubated in the presence of GIP, no effect on intracellular cAMP accumulation was detected. In contrast, the inclusion of 10 nM GIP in the incubation medium increased cAMP accumulation in rat fat cells and differentiated 3T3-L1 cells. This increase in cAMP accumulation was abolished with the specific GIP receptor antagonist GIP(7-30)NH2. The results of these studies indicate that GIP receptors are present in fat cells and are up-regulated when 3T3-L1 cells undergo differentiation to become adipocytes. Furthermore, the increase in intracellular cAMP accumulation detected upon ligand binding indicates that these receptors are functional.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724057     DOI: 10.1210/endo.139.9.6288

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  57 in total

1.  Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110β isoform of phosphatidylinositol 3-kinase.

Authors:  Sameer Mohammad; Lavoisier S Ramos; Jochen Buck; Lonny R Levin; Francesco Rubino; Timothy E McGraw
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

Review 2.  The role of gut hormones in glucose homeostasis.

Authors:  Daniel J Drucker
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents.

Authors:  C E Moss; W J Marsh; H E Parker; E Ogunnowo-Bada; C H Riches; A M Habib; M L Evans; F M Gribble; F Reimann
Journal:  Diabetologia       Date:  2012-08-08       Impact factor: 10.122

Review 4.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

5.  Brown adipose tissue is associated with systemic concentrations of peptides secreted from the gastrointestinal system and involved in appetite regulation.

Authors:  Maria Chondronikola; Craig Porter; Ioannis Malagaris; Aikaterini A Nella; Labros S Sidossis
Journal:  Eur J Endocrinol       Date:  2017-07       Impact factor: 6.664

6.  A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.

Authors:  Brian Finan; Bin Yang; Nickki Ottaway; David L Smiley; Tao Ma; Christoffer Clemmensen; Joe Chabenne; Lianshan Zhang; Kirk M Habegger; Katrin Fischer; Jonathan E Campbell; Darleen Sandoval; Randy J Seeley; Konrad Bleicher; Sabine Uhles; William Riboulet; Jürgen Funk; Cornelia Hertel; Sara Belli; Elena Sebokova; Karin Conde-Knape; Anish Konkar; Daniel J Drucker; Vasily Gelfanov; Paul T Pfluger; Timo D Müller; Diego Perez-Tilve; Richard D DiMarchi; Matthias H Tschöp
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

7.  GATA-4 upregulates glucose-dependent insulinotropic polypeptide expression in cells of pancreatic and intestinal lineage.

Authors:  Lisa I Jepeal; Michael O Boylan; M Michael Wolfe
Journal:  Mol Cell Endocrinol       Date:  2008-02-08       Impact factor: 4.102

8.  Molecular mechanisms underlying nutrient detection by incretin-secreting cells.

Authors:  Frank Reimann
Journal:  Int Dairy J       Date:  2010-04       Impact factor: 3.032

9.  Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans.

Authors:  Meena Asmar; Lene Simonsen; Sten Madsbad; Bente Stallknecht; Jens Juul Holst; Jens Bülow
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

10.  Glucose-Dependent Insulinotropic Peptide Prevents Serum Deprivation-Induced Apoptosis in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.

Authors:  J L Berlier; I Kharroubi; J Zhang; A Dalla Valle; S Rigutto; M Mathieu; V Gangji; J Rasschaert
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.